1025-16:  Risk Management Considerations When Prescribing Controlled Substances

This presentation defines risk management and liability exposures that APRN's may face when prescribing controlled substances. Potential liability exposures will be illustrated through the use of case examples, discussion and Q & A. Risk mitigation strategies will be presented to help lessen the identified liability exposures.

Presenters: Moira K. Wertheimer, Esq., RN, CPHRM

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation. 

Session Length: 1 hour 27 minutes

Target Audience: APRN

Session Objectives
Upon completion of this presentation, the participant will be able to:

1. Increase awareness of federal and state prescribing regulations and drug diversion programs.
2. Define risk management and liability exposures when prescribing for patients including prescribed controlled substances.
3. Identify the role that prescription drug monitoring programs play when prescibing. 

Keywords: Federal Prescribing Regulations, State Regulations, Telemedicine, Legal, Controlled Substances, Liability, Risk Management 

Continuing Nursing Education
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed. 

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 30th Annual Conference
Hartford, Connecticut
Wednesday, October 19
9:30am - 11:30am

Release Date: July 24, 2017
The contact hours for this session expire:  November 30, 2019